These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 7370074)

  • 1. [Pharmacokinetics and metabolism of desoxymethasone].
    Hornke I; Cavagna F; Christ O; Fehlhaber HW; Kellner HM; Sandow J
    Arzneimittelforschung; 1980; 30(1):47-54. PubMed ID: 7370074
    [No Abstract]   [Full Text] [Related]  

  • 2. Desoxymethasone: a review of its pharmacological properties and therapeutic efficacy in the treatment of dermatoses.
    Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1978 Oct; 16(4):302-21. PubMed ID: 359312
    [No Abstract]   [Full Text] [Related]  

  • 3. [Local treatment of psoriasis and pustulosis palmoplantaris with desoxymethasone ointment 0.25%].
    Gjertsen BT; Nilsen A
    Tidsskr Nor Laegeforen; 1980 Apr; 100(11):632-3. PubMed ID: 6992336
    [No Abstract]   [Full Text] [Related]  

  • 4. Photosensitivity to desoximetasone emollient cream.
    Stierstorfer MB; Baughman RD
    Arch Dermatol; 1988 Dec; 124(12):1870-1. PubMed ID: 3190264
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical experiences with desoximetasone preparations (Topisilon ointment, fatty ointment, lotion) in dermatologic disorders. 8-year study].
    Wysocki R
    Fortschr Med; 1982 Apr; 100(15):708-13. PubMed ID: 7044929
    [No Abstract]   [Full Text] [Related]  

  • 6. [Surprising cure of radiogenic x-ray dermatitis].
    Kuhlmann F
    Fortschr Med; 1981 Jan; 99(4):86-7. PubMed ID: 6456212
    [No Abstract]   [Full Text] [Related]  

  • 7. Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor.
    Lin JH; Chiba M; Balani SK; Chen IW; Kwei GY; Vastag KJ; Nishime JA
    Drug Metab Dispos; 1996 Oct; 24(10):1111-20. PubMed ID: 8894513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic investigation of 17alpha-desoxymethasone (A 41 304) in rats.
    Hayashi S; Sakaguchi T; Ozawa H
    Chem Pharm Bull (Tokyo); 1974 Dec; 22(12):2771-7. PubMed ID: 4468106
    [No Abstract]   [Full Text] [Related]  

  • 9. Sex-dependent pharmacokinetics of indinavir: in vivo and in vitro evidence.
    Lin JH; Chiba M; Chen IW; Nishime JA; Vastag KJ
    Drug Metab Dispos; 1996 Dec; 24(12):1298-306. PubMed ID: 8971134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo metabolism and final disposition of a novel nonsteroidal androgen in rats and dogs.
    Perera MA; Yin D; Wu D; Chan KK; Miller DD; Dalton J
    Drug Metab Dispos; 2006 Oct; 34(10):1713-21. PubMed ID: 16815963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.
    Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M
    Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Species differences in the metabolism of a potent HIV-1 reverse transcriptase inhibitor L-738,372. In vivo and in vitro studies in rats, dogs, monkeys, and human.
    Prueksaritanont T; Balani SK; Dwyer LM; Ellis JD; Kauffman LR; Varga SL; Pitzenberger SM; Theoharides AD
    Drug Metab Dispos; 1995 Jul; 23(7):688-95. PubMed ID: 7587955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of capravirine as a CYP3A probe substrate: in vitro and in vivo metabolism of capravirine in rats and dogs.
    Bu HZ; Zhao P; Kang P; Pool WF; Wu EY; Shetty BV
    Drug Metab Dispos; 2007 Sep; 35(9):1593-602. PubMed ID: 17567732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical pharmacokinetics of a novel HIV-1 attachment inhibitor BMS-378806 and prediction of its human pharmacokinetics.
    Yang Z; Zadjura L; D'Arienzo C; Marino A; Santone K; Klunk L; Greene D; Lin PF; Colonno R; Wang T; Meanwell N; Hansel S
    Biopharm Drug Dispos; 2005 Dec; 26(9):387-402. PubMed ID: 16142720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism and pharmacokinetics of a dipeptidyl peptidase IV inhibitor in rats, dogs, and monkeys with selective carbamoyl glucuronidation of the primary amine in dogs.
    Beconi MG; Mao A; Liu DQ; Kochansky C; Pereira T; Raab C; Pearson P; Lee Chiu SH
    Drug Metab Dispos; 2003 Oct; 31(10):1269-77. PubMed ID: 12975337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition of remoxipride in different species. Species differences in metabolism.
    Widman M; Nilsson LB; Bryske B; Lundström J
    Arzneimittelforschung; 1993 Mar; 43(3):287-97. PubMed ID: 8489555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro-in vivo correlation of the pharmacokinetics of vinpocetine.
    Szakács T; Veres Z; Vereczkey L
    Pol J Pharmacol; 2001; 53(6):623-8. PubMed ID: 11985336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of the dipeptidyl peptidase 4 inhibitor saxagliptin in rats, dogs, and monkeys and clinical projections.
    Fura A; Khanna A; Vyas V; Koplowitz B; Chang SY; Caporuscio C; Boulton DW; Christopher LJ; Chadwick KD; Hamann LG; Humphreys WG; Kirby M
    Drug Metab Dispos; 2009 Jun; 37(6):1164-71. PubMed ID: 19251818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
    Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Species differences in metabolism and pharmacokinetics of a sphingosine-1-phosphate receptor agonist in rats and dogs: formation of a unique glutathione adduct in the rat.
    Anari MR; Creighton MD; Ngui JS; Tschirret-Guth RA; Teffera Y; Doss GA; Tang W; Yu NX; Ciccotto SL; Hobra DF; Coleman JB; Vincent SH; Evans DC
    Drug Metab Dispos; 2006 Aug; 34(8):1367-75. PubMed ID: 16698892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.